Company: RPTX
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0000950170-25-105468
Chunk: 0

Company: Repare Therapeutics Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Item 1
Chunk 0
---
Repare Therapeutics Inc.

Condensed Consolidated Balance Sheets 

(Unaudited) 

(Amounts in thousands of U.S. dollars, except share data) 

     As of June 30,

     As of December 31,

     2025

     2024

     ASSETS

     CURRENT ASSETS:

     Cash and cash equivalents
      
     $
     67,656

     $
     84,717

     Marketable securities

     41,816

     68,074

     Income tax receivable

     9,922

     10,600

     Other current receivables

     4,697

     1,746

     Prepaid expenses

     2,481

     6,012

     Total current assets

     126,572

     171,149

     Property and equipment, net

     72

     2,294

     Operating lease right-of-use assets

     629

     1,924

     Income tax receivable

     1,029

     960

     Investment in equity securities

     1,591

     —

     Other assets

     600

     179

     TOTAL ASSETS
      
     $
     130,493

     $
     176,506

     LIABILITIES AND SHAREHOLDERS’ EQUITY

     CURRENT LIABILITIES:

     Accounts payable
      
     $
     4,012

     $
     3,623

     Accrued expenses and other current liabilities

     12,167

     19,819

     Deferred collaboration cost recovery

     3,257

     —

     Operating lease liability, current portion

     649

     1,845

     Total current liabilities

     20,085

     25,287

     Operating lease liability, net of current portion

     —

     88

     TOTAL LIABILITIES

     20,085

     25,375

     SHAREHOLDERS’ EQUITY

     Preferred shares, no par value per share; unlimited shares authorized as of   June 30, 2025 and December 31, 2024; 0 shares issued and outstanding   as of June 30, 2025, and December 31, 2024

     —

     —

     Common shares, no par value per share